- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BI 425809 dose 3
Total 601 results
-
Boehringer IngelheimCompletedAlzheimer DiseaseSpain, United Kingdom, Italy, United States, Canada, Germany, Greece, Austria, Norway, France, Japan, Hungary, Poland, Finland
-
Boehringer IngelheimCompletedSchizophreniaSpain, Korea, Republic of, United Kingdom, Taiwan, United States, Austria, Italy, Germany, Poland, Japan, Canada
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHepatic InsufficiencyGermany
-
Boehringer IngelheimCompletedLupus NephritisSpain, United Kingdom, United States, Canada, Thailand, Germany, Italy, Japan, Serbia, Australia, Korea, Republic of, Mexico, Malaysia, Philippines, Poland, Portugal, Greece, Hong Kong, Czechia, France
-
Boehringer IngelheimCompletedSchizophreniaUnited States, United Kingdom, Australia, Canada, France, New Zealand
-
Boehringer IngelheimCompletedRenal InsufficiencyGermany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHealthyKorea, Republic of
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimRecruitingSchizophreniaKorea, Republic of, Canada, United States, Taiwan, United Kingdom, Chile, Serbia, Brazil, China, Colombia, Germany, Greece, Italy, Japan, Mexico, Norway, Poland, Sweden, Spain, Argentina, Croatia, France, Slovakia, Denmark, Malaysia, Czechia and more
-
Boehringer IngelheimRecruitingSchizophreniaUnited States, Taiwan, Argentina, Brazil, Serbia, Germany, China, Mexico, Korea, Republic of, Bulgaria, United Kingdom, Czechia, Denmark, Austria, Lithuania, Portugal, Belgium, Finland
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
AbbVieBoehringer IngelheimCompletedPsoriasisUnited States, Germany, United Kingdom
-
Rutgers, The State University of New JerseyCenters for Disease Control and PreventionCompletedViolence | Helping Behavior | Sexual Assault and Rape | Assaultive BehaviorUnited States
-
Boehringer IngelheimCompletedHepatitis C, ChronicFrance, Germany, Switzerland
-
PfizerCompletedFungal InfectionNetherlands
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Croatia, Czech Republic, Denmark, Estonia, France, Georgia, Greece, Hong Kong, Hungary, India, Indonesia, Israel, Italy, Japan, Korea, Republic of, Malaysia and more
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Czech Republic, Russian Federation, Ukraine
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
-
Loyola UniversityNational Cancer Institute (NCI)Active, not recruiting
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Denmark, France, Ireland, Korea, Republic of, Portugal, United Kingdom
-
Presidio Pharmaceuticals, Inc.Boehringer IngelheimCompletedChronic Hepatitis CUnited States
-
ReAlta Life Sciences, Inc.FGK Clinical Research GmbHCompleted
-
Autoimmune Technologies, LLCCompleted
-
Galapagos NVCompletedCystic FibrosisUnited Kingdom, Australia, Ireland, Germany, Czech Republic
-
Aronora, Inc.Completed
-
Medigene AGWithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myeloproliferative Disorders | Multiple Myeloma | Myelofibrosis | Chronic Myeloid Leukemia | Acute Lymphoid Leukemia | Malignant LymphomaNetherlands
-
OSE ImmunotherapeuticsBoehringer IngelheimActive, not recruitingSolid Tumor, AdultFrance, Belgium
-
ObsEva SACompletedInfertilityPoland, United Kingdom, Spain, Belgium, Denmark, Czechia
-
Boehringer IngelheimCompletedHepatitis C, ChronicUnited States, Germany, Spain, United Kingdom
-
Boehringer IngelheimCompleted